Clinical Trial Update: Metformin Hydrochloride Sustained-release Tablets (Ⅲ) in Patients With Type 2 Diabetes Mellitus Complicated With Coronary Heart Disease [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update evaluating metformin hydrochloride sustained-release tablets in patients with type 2 diabetes mellitus and atherosclerotic cardiov…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atherosclerotic Cardiovascular Disease
• Type 2 Diabetes Mellitus

Drugs mentioned

• Metformin hydrochloride sustained-release tablets (metformin hydrochloride sustained-release)

Snippet

Sponsor: China National Center for Cardiovascular Diseases | Conditions: Atherosclerotic Heart Disease, Type 2 Diabetes | Phase 4 | Status: RECRUITING